BMI category-specific waist circumference thresholds based on cardiovascular disease outcomes and all-cause mortality: Tehran lipid and glucose study (TLGS).
Journal
BMC public health
ISSN: 1471-2458
Titre abrégé: BMC Public Health
Pays: England
ID NLM: 100968562
Informations de publication
Date de publication:
05 07 2023
05 07 2023
Historique:
received:
02
10
2022
accepted:
26
06
2023
medline:
7
7
2023
pubmed:
6
7
2023
entrez:
5
7
2023
Statut:
epublish
Résumé
Waist circumference (WC), a representative of abdominal visceral fat, is strongly associated with cardiovascular disease (CVD) and its outcomes. We aimed to define body mass index (BMI)-specific WC thresholds as predictors of CVD and all-cause mortality. In this prospective cohort study in the context of the Tehran Lipid and Glucose Study (TLGS), a total of 3344 men and 4068 women were followed up for 18 years. Based on BMI, the participants were categorized into three groups: BMI < 25, 25 < BMI < 30, and BMI > 30. In each BMI category, sex-specific WC thresholds were estimated by the maximum value of Youden's index to predict based on incident CVD events and all-cause mortality prediction. Overall 667 and 463 CVD events (the incidence rate of 3.1 to 4.5 in men and 1.1 to 2.6 in women per 1,000 person-years within BMI categories) and 438 and 302 mortalities (the incidence rate of 2.1 to 2.7 in men and 1.2 to 1.4 in women per 1,000 person-years within BMI categories) were recorded in men and women, respectively. WC thresholds in the BMI categories of < 25, 25-30, and BMI > 30 kg/m BMI-specific WC thresholds observed here can help to better identify individuals at high risk of developing CVDs.
Sections du résumé
BACKGROUND
Waist circumference (WC), a representative of abdominal visceral fat, is strongly associated with cardiovascular disease (CVD) and its outcomes. We aimed to define body mass index (BMI)-specific WC thresholds as predictors of CVD and all-cause mortality.
METHODS
In this prospective cohort study in the context of the Tehran Lipid and Glucose Study (TLGS), a total of 3344 men and 4068 women were followed up for 18 years. Based on BMI, the participants were categorized into three groups: BMI < 25, 25 < BMI < 30, and BMI > 30. In each BMI category, sex-specific WC thresholds were estimated by the maximum value of Youden's index to predict based on incident CVD events and all-cause mortality prediction.
RESULTS
Overall 667 and 463 CVD events (the incidence rate of 3.1 to 4.5 in men and 1.1 to 2.6 in women per 1,000 person-years within BMI categories) and 438 and 302 mortalities (the incidence rate of 2.1 to 2.7 in men and 1.2 to 1.4 in women per 1,000 person-years within BMI categories) were recorded in men and women, respectively. WC thresholds in the BMI categories of < 25, 25-30, and BMI > 30 kg/m
CONCLUSION
BMI-specific WC thresholds observed here can help to better identify individuals at high risk of developing CVDs.
Identifiants
pubmed: 37407928
doi: 10.1186/s12889-023-16190-w
pii: 10.1186/s12889-023-16190-w
pmc: PMC10324109
doi:
Substances chimiques
Lipids
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1297Informations de copyright
© 2023. The Author(s).
Références
Obesity (Silver Spring). 2009 Dec;17(12):2232-8
pubmed: 19360008
JAMA. 2014 Feb 5;311(5):507-20
pubmed: 24352797
N Engl J Med. 2017 Jul 6;377(1):13-27
pubmed: 28604169
Clin Chem. 1972 Jun;18(6):499-502
pubmed: 4337382
Mayo Clin Proc. 2014 Mar;89(3):335-45
pubmed: 24582192
Int J Obes (Lond). 2012 Nov;36(11):1450-4
pubmed: 22249224
Public Health Nutr. 2014 Apr;17(4):861-9
pubmed: 23481553
BMC Pediatr. 2021 Nov 6;21(1):494
pubmed: 34742260
Diabetes Care. 2005 Jan;28 Suppl 1:S37-42
pubmed: 15618111
Postgrad Med J. 2021 May;97(1147):306-311
pubmed: 32371408
J Am Coll Cardiol. 2001 Nov 1;38(5):1581-3
pubmed: 11691544
Zhonghua Nei Ke Za Zhi. 2006 May;45(5):372-5
pubmed: 16780737
J Clin Epidemiol. 2008 Jul;61(7):646-53
pubmed: 18359190
Eur Heart J. 2013 Feb;34(5):345-53
pubmed: 22947610
Arch Intern Med. 2010 Aug 9;170(15):1293-301
pubmed: 20696950
Int J Obes (Lond). 2009 Dec;33(12):1437-45
pubmed: 19752876
Circulation. 2003 Nov 18;108(20):2543-9
pubmed: 14610011
Eur J Cardiovasc Prev Rehabil. 2009 Dec;16(6):729-34
pubmed: 19809330
Nat Rev Endocrinol. 2020 Mar;16(3):177-189
pubmed: 32020062
Public Health Nutr. 2015 Nov;18(16):2981-9
pubmed: 25711365
Obes Res. 2004 Jul;12(7):1094-103
pubmed: 15292473
Trials. 2009 Jan 25;10:5
pubmed: 19166627
Ups J Med Sci. 2019 Jan;124(1):78-82
pubmed: 30256695
Circulation. 2009 Oct 20;120(16):1640-5
pubmed: 19805654
Diabetes Res Clin Pract. 2008 Oct;82(1):104-7
pubmed: 18706730
J Nutr Health Aging. 2018;22(8):975-981
pubmed: 30272102
Clin J Am Soc Nephrol. 2011 Jul;6(7):1722-30
pubmed: 21734088
Metab Syndr Relat Disord. 2010 Jun;8(3):209-13
pubmed: 20085488
N Engl J Med. 2008 Nov 13;359(20):2105-20
pubmed: 19005195
Am J Kidney Dis. 2011 Aug;58(2):177-85
pubmed: 21601327
Lancet. 2014 Aug 30;384(9945):766-81
pubmed: 24880830
Obes Facts. 2013;6(4):317-24
pubmed: 23970141
Diabetes Care. 2007 Jun;30(6):1647-52
pubmed: 17360974
Intern Med. 2012;51(2):139-46
pubmed: 22246480
Mayo Clin Proc. 2010 Feb;85(2):112-4
pubmed: 20118385
Obesity (Silver Spring). 2015 Apr;23(4):879-85
pubmed: 25755157
Obes Res Clin Pract. 2017 Jan - Feb;11(1):19-26
pubmed: 27364234
Int J Obes (Lond). 2007 Oct;31(10):1552-3
pubmed: 17549092
Circulation. 2007 Jul 3;116(1):39-48
pubmed: 17576866
Obesity (Silver Spring). 2009 Aug;17(8):1615-20
pubmed: 19265793
J Clin Med. 2019 Jan 10;8(1):
pubmed: 30634601
BMJ. 1995 Jul 15;311(6998):158-61
pubmed: 7613427
Int J Epidemiol. 2012 Jun;41(3):805-17
pubmed: 22467292
Nutr Rev. 1998 Apr;56(4 Pt 1):106-14
pubmed: 9584495
Circulation. 2008 Apr 1;117(13):1658-67
pubmed: 18362231
J Atheroscler Thromb. 2010 May;17(5):468-75
pubmed: 20057171
Arch Intern Med. 2002 Oct 14;162(18):2074-9
pubmed: 12374515